Hemas Holdings PLC Investor Presentation Q3 - 2015/16

1. Investor Presentation
For the Nine Months ending December 31, 2015
1

2. Table of Contents
2
1 Hemas Business : Revenue and Profitability by Sector
2 History and Milestones
3 Consolidated YTD Group Performance
4 Consumer
5 Healthcare
6 Transportation
7 Leisure
8 Sustainability
9 Vision 2020

3. Hemas is a Wellness, Leisure and Travel
Business with YTD LKR 28 billion in revenues
3
Consumer
39%
Healthcare
42%
Leisure
8%
Transportation
5%
Others
6%
Revenue
Segmental Revenue and Operating Profits, YTD 2015/16
Operating Profit (Rs. Mn) Q3 YTD 2014/15
Consumer 1,384
Healthcare 1,285
Leisure 191
Transportation 271
Other (269)
Total 2,862
-350
0
350
700
1050
1400
Consumer Healthcare Leisure Transportation Other
Rs.Millions

4. History and Milestones
4
201420132011
Entry into
Bangladesh
2007
Entered the
Hospital
business via
Acquisition
20031970s
Diversified into
travel & tourism
1962
Entered the
Consumer
business
1948
Founded
Hemas Drugs
Ltd.
Acquired J.L
Morison Son &
Jones
(Ceylon)
PLC
Exited
non-core
business
Hemas Holdings
Listed on
CSE

5. Performance Indicator (Rs. Mn)
Q3 YTD
2014/15
Q3 YTD
2015/16
% Change
Group Revenue 23,640 28,287 19.7%
Operating Profit 2,214 2,785 25.8%
Profit After Tax 1,501 2,036 35.7%
Group Earnings 1,155 1,909 65.2%
Performance Indicator
Q3 YTD
2014/15
Q3 YTD
2015/16
% Change
ROE* 11.06% 14.45%
ROCE* 12.88% 14.09%
EPS 2.24 3.33 48.7%
Net Assets per Share 28.69 35.69 24.4%
Share Price (Dec 31) 74.30 93.00
Market Cap Rs. Mn (Dec 31) 38,286 53,247
Consolidated YTD Q3 revenues of 2015/16 was LKR 28 Bn, up
19.7% over the previous year, with Group Earnings up 65.2%
Growth coming primarily from strong performance in Consumer and Healthcare sectors.
Hemas Holdings PLC, Q3 YTD 2015/16
* Annualized based on Q3 results
• HHL recorded solid Q3 YTD performance with consolidated
Group revenue of Rs. 28.3 Bn—a YoY growth of 19.7%.
• Operating profit reached Rs. 2.8Bn and earnings Rs. 1.9Bn,
a growth of 25.6% and 65.2% respectively.
• Good growth recorded by Consumer and Healthcare
sectors of 24% and 18% respectively.
• Eliminating one off transactions in the preceding year and
the additional interest income of Rs.196Mn earned from
investing the proceeds of the rights issue, underlying
operating profit and earnings maintained a healthy growth
of 30.8% and 30.2% respectively.
Segmental Revenue Q3
YTD 2015/16
Consumer
39%
Healthcare
42%
Others
6%
Leisure
8%
Transportation
5%
5

6. Consumer
6

7. Hemas Consumer is Sri Lanka’s largest domestic Personal
Care business, accounting for over 40% Group Revenues
Hair CareOral CareBaby Care
Feminine Hygiene Home CarePersonal Wash
7

8. Hemas entered Bangladesh in 2011, and today we are the
number 2 value-added hair oil brand with Kumarika
• Kumarika hair oil has 15% market share in the value added oil
segment
• We serve 115,000 retail outlets in municipal towns with a further
20,000 in rural locations.
• 3-year average revenue growth has been 262%.
• We operate our own distribution, through a network of 140
distributors and over 100 sub-distributors
• We have a total 280 sales reps operating in 21 territories.
0
200
400
600
800
1,000
1,200
1,400
1,600
1,800
2010/11 2011/12 2012/13 2013/14 2014/15 2015/16
YTD
Bangladesh Revenue in Rs. Million
8

9. Market leader in personal care, strong iconic brands with
international relevance
Revenues up more than 24% year on year, driven by robust volume growth in personal wash, feminine
hygiene and home care.
• Portfolio comprises personal care, personal wash and
home care products
• Market leader in baby care, hair oil, and beauty soap
• Island wide distribution with direct coverage of
90,000+ stores
• Bangladesh operations poised for accelerated growth
• Introduced new Velvet variant “Honey and Yoghurt”
Sector Highlights
• Consumer sector reported a total revenue of
Rs. 11.2Bn, a 24.4% YoY increase on the previous
financial year
• Sector performance was driven by our Bangladesh
operation, strong sales across all our major brands in
the domestic market and relatively weak commodity
prices for key raw material inputs.
Financial Highlights
Consumer Revenue and Operating Profit
Q3 YTD 2010/11–2015/16
Consumer Revenue Share, YTD FY 2015/16
Consumer
39%Rest of Group
61%
9
'-
350
700
1,050
1,400
1,750
'-
3,000
6,000
9,000
12,000
2010/11 2011/12 2012/13 2013/14 2014/15 2015/16
OperatingProfit-Rs.Million
Revenue-Rs.Million
Revenue Operating Profit

10. Healthcare
10

11. Hemas is the largest healthcare company in Sri Lanka
with interests in Pharma, Hospitals and Diagnostics
Pharmaceutical
Distribution
Rx &
OTC
Pharmaceutical
Manufacturing
Hospitals
11

12. We represent the largest global multinational pharmaceutical
manufacturers
650
Employees
35+
Principals
9
Therapeutic
Categories
22%
Market Share 3000+
Pharmacies
12
Hemas
Pharmaceuticals

13. OTC Own Brands
• Lacto Calamine
• Gripe Mixture
• Baby Cough Syrup
• Valmelix Cough Syrup
JLM, acquired in 2013, is a market leading Rx manufacturer
with leading OTC brands
J.L. Morison Son & Jones
33%
Sales CAGR
Growth since
acquisition
Rs. 000’ FY 2014 FY 2015 YTD
Revenue 2,638,931 3,025,969 2,730,574
Operating
Profit
258,189 324,173 358,606
Earnings 210,757 247,091 281,035
Financial Highlights
13
• Manufacture high quality pharmaceutical and OTC
products
• Import and distribution of internationally renowned
products via our island-wide distribution network

14. Hemas is the first hospital chain to take high quality private
healthcare to rapidly growing Colombo suburbs
• 3 multi-specialty, ACHSI accredited hospitals built on international standards in
the North of Colombo, East of Colombo and in the Southern Province.
• 36 strong satellite lab network, serves over 500 physicians, addressing a
patient population of 5 million.
• Through our new corporate polyclinic model, we are locating in large working
population environments, with a continued focus on bringing healthcare to the
consumer.
14
Wattala 100 beds Thalawathugoda 60 beds Galle 50 beds

15. Deep experience across healthcare value chain with market
leading positions
• Market leader in the pharmaceutical distribution
business, representing more than 25 multinational
pharmaceutical agencies
• Three multi specialty hospitals in Colombo North,
Colombo East and Galle with a combined bed capacity of
210.
• Yet another novel concept - Hemas Hospitals opened its
first wellness centre at Orion City to the 6,000 plus
employee strength, at Colombo’s premier IT park.
Sector Highlights
Financial Highlights
• Healthcare segment of the Group achieved sales of
Rs.11.9Bn, a growth of 18.3%
• Growth of 15% in total Pharma top-line indicates
encouraging performance, during a period of significant
regulatory change in the pharmaceutical industry.
• Increased demand for overall and private healthcare in
the country and the growing diagnostic network of the
Group, all three hospitals recorded a growth in revenue
marking a 29.9% YoY.
Healthcare Revenue and Operating Profit
Q3 YTD FY 2010/11–2015/16
Healthcare Revenue Share, YTD FY 2015/16
Healthcare
42%Rest of Group
58%
15
'-
325
650
975
1,300
1,625
'-
3,000
6,000
9,000
12,000
15,000
2010/11 2011/12 2012/13 2013/14 2014/15 2015/16
OperatingProfit-Rs.Million
Revenue-Rs.Million
Revenue Operating Profit

16. Transportation
16

17. Travel and
Aviation
OutboundMaritimeLogistics
• Hemas offers complete passenger
and cargo solutions in Airline
Representation and travel related
services
• Hemas represents airlines
Emirates, Malaysia Airline and
Maldivian and other major airlines.
• Largest GSA operator in passenger
and cargo with a market share of
25% and 20%, respectively
• Grew Emirates airlines from 1 flight
per day to 7 flights per day
• 5th in the travel market
• Integrated portfolio of
container haulage, container
yard operations, warehousing,
automotive logistics and
transportation of project and
over-dimensional cargo.
• 6 acre container terminal.
• Maritime sector acts as a
shipping agent providing
agency services for our feeder
operator.
• Far Shipping Lines (FSL)
Singapore
• Operates the largest feeder
service to the Bay of Bengal
• Award winning, IATA
accredited travel agency.
• Corporate travel service is a
network partner of HRG which
offers global travel services
and hotel reservations.
17
Through our transportation arm, we are securing new accounts
and growing capacity in logistics, warehousing and haulage

18. Transportation
5%
Rest of Group
95%
Our Transportation business had YTD 1.3 billion in revenues, a
year-on-year growth of 15%
• Leader in airline representation including GSA’s for
Emirates, Malaysia Airlines and China Southern
• Regional GSA representation in Maldives and Thailand
• Exclusive shipping agent for Far Shipping Lines, a leading
regional feeder operator
• Exclusive agent for ‘HC line’ and NVOCC operator ‘Asian
Tiger Shipping’
• Strategic investments in logistics verticals providing
integrated end to end solutions
Sector Highlights
Financial Highlights
• Transportation sector revenue of Rs.1.3 Bn reflects a YoY
growth of 15.2%, stemming from strong performance of our
domestic maritime and logistics business interests.
• Logistics business grew through new projects, with our
warehouses operating with full capacity and haulage business
growing with the car carrier operation.
• Aviation businesses continued to experience challenges due
to lower yields of ticketing income despite increases in
volumes.
• Driven by limited revenue growth from aviation transportation
sector operating profits declined 6.1% to Rs.271Mn.
Transportation Revenue and Operating Profit
Q3 YTD FY 2010/11–2015/16
Transportation Revenue Share, YTD FY
2015/16
18
'-
85
170
255
340
425
'-
325
650
975
1,300
1,625
2010/11 2011/12 2012/13 2013/14 2014/15 2015/16
OperatingProfit-Rs.Million
Revenue-Rs.Million
Revenue Operating Profit

19. Leisure
19

20. Our Leisure business comprises leading travel brands and an
inbound leisure business
• Serendib Leisure Group of Hotels which, includes four award winning
properties with a total inventory of 550 rooms.
• The partnership with Minor Hotel Group (MHG) has enabled Serendib
Leisure to be the only Sri Lankan hotel chain to manage an international
brand, “AVANI”.
Coming Soon
20

21. We are investing in Sri Lanka’s tourism boom with a selection of
new builds, targeting the upper star class segment of the market
YTD revenues of LKR 2.2Bn, with around a 9.2% increase year on year.
• Owner and Manager of four properties with a
combined room inventory of 410.
• Strategic partnership with Minor Hotel Group, a
leading Asian hotel chain.
• During December, opened our newest hotel property,
Anantara Peace Haven Tangalle Resort, this property
will establish a new benchmark for luxury travellers to
Sri Lanka seeking authentic cultural experiences.
Sector Highlights
Financial Highlights
• Leisure segment recorded a total revenue of Rs.
2.2Bn for the nine months under consideration,
registering a 9.2% YoY increase .
• The increase was primarily driven by the healthy
overall occupancy rate of 78%.
• The new hotels first month of operation has been
encouraging.
Leisure Revenue and Operating Profit
Q3 YTD FY 2010/11–2015/16
Leisure Revenue Share, YTD FY 2015/16
Leisure
8%
Rest of Group
92%
21
'-
65
130
195
260
325
'-
550
1,100
1,650
2,200
2,750
2010/11 2011/12 2012/13 2013/14 2014/15 2015/16
OperatingProfit-Rs.Million
Revenue-Rs.Million
Revenue Operating Profit

22. Sustainability
22

23. Enriching lives through the spirit of Abhimana
• Abhimana’ is our ethos of sustainability that
describes our vision of a sustainable and co-
operative society, of people living and working
together
• Inline with this, we have released our Sustainability
Report providing insight into the Group’s
sustainability philosophy and initiatives in line with
the Global Reporting Initiative G4 guidelines (GRI-
G4) : http://www.hemas.com/reports
• Today, our strategic path is governed not only by
how well we develop growing commercial
opportunities but also by listening to and
responding to the communities of which we are a
part.
23

24. Piyawara
• The Hemas ‘Piyawara’ project focuses on early
childhood care and development, penetrating the
segment by facilitating preschool education for
children aged 3 to 5 years, from marginalised
communities.
• With the mission “to nurture young children with
good care in order to provide a solid foundation of
a life long journey”
24

25. Vision 2020 - To be the best at enriching lives
• Delighting South Asian consumers with our high quality innovative personal care
solutions
• Providing excellent healthcare outcomes for all Sri Lankans
• Outstanding leisure experiences to the emerging traveler
• Driving exceptional mobility solutions for the travel and logistics needs of the nation
• While at all times operating true to Hemas Values and our ethos of Abhimana
25
2020
Vision

26. Thank You
CONFIDENTIALITY AGREEMENT:
Any confidential information discussed in this presentation shall be used by the receiving party exclusively for the purposes
of fulfilling the receiving party’s obligation and for no other purpose except with the consent of the disclosing party
Hemas Investor Relations:
Telephone: +94 11 4 731 731
Email: ir@hemas.com
Web: http://www.hemas.com
Hemas Holdings PLC
Hemas House, 75, Braybrooke Place,
Colombo 2, Sri Lanka
26